Inflammation, kidney function and albuminuria in the Framingham Offspring cohort
- PMID: 20682604
- PMCID: PMC3108344
- DOI: 10.1093/ndt/gfq471
Inflammation, kidney function and albuminuria in the Framingham Offspring cohort
Abstract
Background: Inflammation and chronic kidney disease (CKD) are both associated with cardiovascular disease (CVD). Whether inflammatory biomarkers are associated with kidney function and albuminuria after accounting for traditional CVD risk factors is not completely understood.
Methods: The sample comprised Framingham Offspring cohort participants (n = 3294, mean age 61, 53% women) who attended the seventh examination cycle (1998-2001). Inflammatory biomarkers [C-reactive protein (CRP), tumour necrosis factor (TNF)-alpha, interleukin-6, TNF receptor 2 (TNFR2), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1), P-selectin, CD-40 ligand, osteoprotegerin, urinary isoprostanes, myeloperoxidase and fibrinogen] were measured on fasting blood samples. Serum creatinine-based estimated glomerular filtration rate (eGFR) and serum cystatin C concentration were used to assess kidney function. Urinary albumin-to-creatinine ratio (UACR) was used to assess albuminuria. Linear or logistic regression was used to test associations between biomarkers and kidney measures.
Results: Chronic kidney disease (CKD), defined as eGFR < 59/64 mL/min/1.73 m(2) in women/men, was present in 8.8% (n = 291) of participants. TNF-alpha, interleukin-6, TNFR2, MCP-1, osteoprotegerin, myeloperoxidase and fibrinogen were higher among individuals with CKD; all biomarkers except for urinary isoprostanes were elevated in higher cystatin C quartiles; and TNF-alpha, interleukin-6, TNFR2, ICAM-1 and osteoprotegerin were elevated in higher UACR quartiles-all assessed after multivariable adjustment. Almost 6% and 17% of variability in TNFR2 were explained by CKD status and higher cystatin C quartiles, respectively.
Conclusions: Biomarkers of inflammation are associated with kidney function and albuminuria. In particular, substantial variability in soluble TNFR2 is explained by CKD and cystatin C.
Figures

Similar articles
-
Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.Clin J Am Soc Nephrol. 2012 Dec;7(12):1938-46. doi: 10.2215/CJN.03500412. Epub 2012 Sep 27. Clin J Am Soc Nephrol. 2012. PMID: 23024164 Free PMC article.
-
Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.Am J Kidney Dis. 2021 Mar;77(3):386-396.e1. doi: 10.1053/j.ajkd.2020.09.015. Epub 2020 Nov 14. Am J Kidney Dis. 2021. PMID: 33197533
-
Biological Variability of Estimated GFR and Albuminuria in CKD.Am J Kidney Dis. 2018 Oct;72(4):538-546. doi: 10.1053/j.ajkd.2018.04.023. Epub 2018 Jul 18. Am J Kidney Dis. 2018. PMID: 30031564 Free PMC article.
-
Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction.Nephron Clin Pract. 2011;119(2):c171-7; discussion c177-8. doi: 10.1159/000325669. Epub 2011 Jul 28. Nephron Clin Pract. 2011. PMID: 21811078 Review.
-
Kidney Disease in Diabetes.In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 22. In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 22. PMID: 33651560 Free Books & Documents. Review.
Cited by
-
Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease.BMC Nephrol. 2015 May 30;16:77. doi: 10.1186/s12882-015-0068-7. BMC Nephrol. 2015. PMID: 26025192 Free PMC article.
-
Plasma MCP-1 and TGF-β1 Levels are Associated with Kidney Injury in Children with Congenital Anomalies of the Kidney and Urinary Tract.Appl Biochem Biotechnol. 2024 Sep;196(9):6222-6233. doi: 10.1007/s12010-023-04808-z. Epub 2024 Jan 20. Appl Biochem Biotechnol. 2024. PMID: 38244151
-
Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate.PLoS One. 2012;7(7):e41281. doi: 10.1371/journal.pone.0041281. Epub 2012 Jul 19. PLoS One. 2012. PMID: 22829936 Free PMC article.
-
Relationship between estimated glomerular filtration rate, albuminuria, and oxidant status in the Japanese population.BMC Nephrol. 2013 Sep 9;14:191. doi: 10.1186/1471-2369-14-191. BMC Nephrol. 2013. PMID: 24016221 Free PMC article.
-
Effect of renal impairment on cognitive function during a 3-year follow up in elderly patients with type 2 diabetes: Association with microinflammation.J Diabetes Investig. 2014 Sep;5(5):597-605. doi: 10.1111/jdi.12190. Epub 2014 Feb 4. J Diabetes Investig. 2014. PMID: 25411629 Free PMC article.
References
-
- Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305. - PubMed
-
- Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003;41:47–55. - PubMed
-
- Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663. - PubMed
-
- Cachofeiro V, Goicochea M, de Vinuesa SG, et al. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl. 2008;74:S4–S9. - PubMed
-
- Fried L, Solomon C, Shlipak M, et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004;15:3184–3191. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL064753/HL/NHLBI NIH HHS/United States
- N01 HC025195/HC/NHLBI NIH HHS/United States
- R01-HL-64753/HL/NHLBI NIH HHS/United States
- AG028321/AG/NIA NIH HHS/United States
- K24-DK080140/DK/NIDDK NIH HHS/United States
- K24 DK080140/DK/NIDDK NIH HHS/United States
- R01-HL04334/HL/NHLBI NIH HHS/United States
- R01 HL043302/HL/NHLBI NIH HHS/United States
- R01 AG028321/AG/NIA NIH HHS/United States
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- R01-HL-076784/HL/NHLBI NIH HHS/United States
- R01-HL70139/HL/NHLBI NIH HHS/United States
- R01 HL076784/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous